Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

264.34 -0.78 (-0.29%)
Official Closing Price Updated: 7:00 PM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,541,470
Open 265.49
Bid (Size) 264.00 (100)
Ask (Size) 265.20 (800)
Prev. Close 265.12
Today's Range 262.59 - 266.00
52wk Range 190.75 - 269.39
Shares Outstanding N/A
Dividend Yield 2.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
AbbVie bets on pipeline diversification amid patent cliffs, while J&J's higher profitability masks litigation risks, a choice between growth ambition and defensive stability. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026? ↗
AbbVie pivots toward newer immunology drugs while Pfizer leans on acquisitions to offset pandemic decline, but their financial profiles and valuations tell starkly different stories. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+15.3%
+15.3%
1 Month
-0.5%
-0.5%
3 Month
+8.7%
+8.7%
6 Month
+25.2%
+25.2%
1 Year
+20.2%
+20.2%

More News

Read More
News headline image
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September? ↗
Via The Motley Fool
News headline image
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
Via StockStory
Topics Artificial Intelligence
News headline image
AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded? ↗
Via The Motley Fool
Topics Economy
News headline image
Is AbbVie the Best Dividend King to Buy in September? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Dividend Stocks That Are No-Brainer Buys Right Now, Starting With This Healthcare Giant ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie Maps Post-HUMIRA Growth With Apogee Deal, Immunology Pipeline ↗
Via MarketBeat
Topics ETFs
News headline image
Billionaire Ken Griffin Just Loaded Up on This Dividend King, and Wall Street Still Sees Upside ↗
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Why Did Billionaire Israel "Izzy" Englander More Than Double His Stake in AbbVie Stock and Start a Position in SpaceX Stock? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years ↗
Via Benzinga
News headline image
AbbVie Highlights SKYRIZI, RINVOQ Growth and Pipeline Catalysts at Wells Fargo Conference ↗
Via MarketBeat
News headline image
2 Dividend Stocks Built to Hold Up When Markets Don't ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Billionaire Israel Englander Is Doubling Down on These 2 Outstanding Dividend Stocks. Should You? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Move Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
If I Were in My 20s, I'd Buy This Vanguard ETF Warren Buffett Recommended and Hold It Forever ↗
Via The Motley Fool
Topics ETFs Economy
News headline image
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It ↗
Via MarketBeat
Topics Artificial Intelligence Bonds
News headline image
3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King) ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 264.34
When was AbbVie last traded?
The last trade of AbbVie was at 09/25/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.